LiverLearning®: 2019 Webinar: HCV Treatment in Patients with IDU
Injection Drug Use (IDU) remains the leading risk factor for HCV. Unfortunately, significant obstacles limit every aspect of the HCV care cascade in this population.
Issue Information
21 May 2019
Issue Information
21 May 2019
Issue Information
21 May 2019
Erratum
21 May 2019
Erratum
21 May 2019
Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult‐to‐Adult Living Donor Liver Transplantation
Toru Ikegami, Tomoharu Yoshizumi, Norifumi Harimoto, Masaki Mori – 20 May 2019